Filed Pursuant to Rule 424(b)(5)
Registration No. 333-277383
PROSPECTUS SUPPLEMENT
(To Prospectus dated February 27, 2024)
Up to $200,000,000 of Shares of
Common Stock
We have entered into an “at-the-market” equity offering distribution agreement, referred in this prospectus supplement as the “distribution agreement,” dated as of February 27, 2024, with KeyBanc Capital Markets Inc., Robert W. Baird & Co. Incorporated, Barclays Capital Inc., Berenberg Capital Markets LLC, BMO Capital Markets Corp., B. Riley Securities, Inc., Capital One Securities, Inc., Colliers Securities LLC, Citizens JMP Securities, LLC, Scotia Capital (USA) Inc., Truist Securities, Inc., Wells Fargo Securities, LLC, Barclays Bank PLC, Bank of Montreal, The Bank of Nova Scotia, Truist Bank and Wells Fargo Bank, National Association (and, in certain cases, their respective affiliates), in their capacity as Sales Agents, Forward Purchasers and/or Forward Sellers, in each case as described below, relating to our shares of common stock, $0.01 par value per share (“common stock”), offered by this prospectus supplement and the accompanying prospectus pursuant to a continuous offering program. We refer to these entities, when acting in their capacity as sales agents, individually as a “Sales Agent” and collectively as “Sales Agents,” when acting in their capacity as agents for Forward Purchasers, individually as a “Forward Seller” and collectively as “Forward Sellers” and when acting in their capacity as forward purchasers pursuant to forward sale agreements, individually as a “Forward Purchaser” and collectively as “Forward Purchasers.”
The distribution agreement provides that, in addition to the issuance and sale of common stock by us to or through the Sales Agents, we may enter into one or more forward sale agreements with the Forward Purchasers. In connection with any forward sale agreement, the relevant Forward Purchaser will, at our request, use commercially reasonable efforts consistent with its normal trading and sales practices for similar transactions and applicable law and regulation, to borrow from third parties and, through its affiliated Forward Seller, sell a number of shares of common stock equal to the number of shares of common stock underlying the particular forward sale agreement. In no event will the aggregate number of shares of common stock sold through the Sales Agents or Forward Sellers (or directly to the Sales Agents, acting as principals under the distribution agreement or under any terms agreement (as described below)) have an aggregate gross sales prices in excess of $200,000,000.
Sales of our common stock, if any, made through the Sales Agents, acting as our sales agents, or the Forward Sellers, acting as agents for the Forward Purchasers, or directly to a Sales Agent, acting as principal, as contemplated by this prospectus supplement and the accompanying prospectus, may be made by means of ordinary brokers’ transactions, including directly on the New York Stock Exchange, (“NYSE”), the existing trading market for our common stock, by means of negotiated transactions or otherwise at market prices prevailing at the time of sale, at prices relating to prevailing market prices or at negotiated prices.
No Sales Agent, acting as our sales agent, or Forward Seller, acting as agent for the applicable Forward Purchaser, is required to sell any specific number or dollar amount of shares of common stock, but each has agreed to use its commercially reasonable efforts, as our sales agent or as agents for the applicable Forward Purchaser, as applicable, consistent with its normal trading and sales practices and applicable law and regulation and on the terms and subject to the conditions of the distribution agreement, to sell the shares offered as instructed by us. The common stock offered and sold through the Sales Agents, as our sales agents, or the Forward Sellers, as agents for the applicable Forward Purchaser, pursuant to this prospectus supplement and the accompanying prospectus, will be offered and sold through only one Sales Agent or Forward Seller on any given day.
Each Sales Agent will be entitled to compensation not to exceed 2.0% of the gross sales price of all shares of common stock sold through it as sales agent under the distribution agreement. In connection with any forward sale agreement, we will pay the relevant Forward Seller, in the form of a reduced initial forward sale price under the related forward sale agreement with the related Forward Purchaser, commissions at a mutually agreed rate that will not exceed 2.0% of the gross sales price of all borrowed shares of common stock sold during the applicable forward hedge selling period by it as a Forward Seller.
Under the terms of the distribution agreement, we also may sell shares of our common stock to any of the Sales Agents, as principal, at a price agreed upon at the time of sale. If we sell shares to a Sales Agent as principal, we will enter into a separate terms agreement with that Sales Agent and will describe the terms of the offering of those shares in a separate prospectus supplement.
The net proceeds we receive from the sale of our common stock in this offering will be the gross proceeds received from such sales less the commissions and any other costs we may incur in issuing and/or selling the common stock; provided, however, that we will not receive any proceeds from the sale of common stock by any Forward Seller. We currently expect to fully physically settle each forward sale agreement, if any, with the relevant Forward Purchaser on one or more dates specified by us on or prior to the maturity date of such forward sale agreement, in which case we expect to receive aggregate net cash proceeds at settlement equal to the number of shares specified in such forward sale agreement multiplied by the relevant forward price per share. However, subject to certain exceptions, we may also elect, in our sole discretion, to cash settle or net share settle all or any portion of our obligations under any forward sale agreement, in which case we may not receive any proceeds (in the case of cash settlement) or will not receive any proceeds (in the case of net share settlement), and we may owe cash (in the case of cash settlement) or our common stock (in the case of net share settlement) to the relevant Forward Purchaser. Certain Sales Agents, the Forward Sellers and/or the Forward Purchasers (or affiliates thereof) act as lenders, and, in certain cases, agents, under our credit agreement and term loan agreement and may receive pro rata portions of any proceeds used to repay amounts outstanding under our credit agreement and term loan agreement. See “Plan of Distribution (Conflicts of Interest)” in this prospectus supplement.
Our common stock is listed on the NYSE under the symbol “PLYM.” On February 26, 2024, the last reported sales price of our common stock on the NYSE was $21.71 per share.
Investing in our common stock involves risks. Please carefully read the “Risk Factors” beginning on page S-
6 of this prospectus supplement and in our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q, and the discussion of certain factors you should consider before making your investment decision in the documents incorporated by reference in this prospectus supplement, including our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q or Current Reports filed on Form 8-K.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
KeyBanc Capital
Markets | | | Baird | | | Barclays | | | Berenberg | | | BMO Capital
Markets | | | B. Riley Securities | | | Capital One Securities | | | Colliers
Securities LLC | | | Citizens JMP |
Scotiabank | | | Truist Securities | | | Wells Fargo Securities |
The date of this prospectus supplement is February 27, 2024